Jump to ContentJump to Main Navigation
Best of Five MCQs for the Acute Medicine SCE$
Users without a subscription are not able to see the full content.

Nigel Lane, Louise Powter, and Sam Patel

Print publication date: 2016

Print ISBN-13: 9780199680269

Published to Oxford Scholarship Online: November 2020

DOI: 10.1093/oso/9780199680269.001.0001

Show Summary Details
Page of

PRINTED FROM OXFORD SCHOLARSHIP ONLINE (oxford.universitypressscholarship.com). (c) Copyright Oxford University Press, 2022. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in OSO for personal use.date: 19 May 2022

Oncology and Palliative Care

Oncology and Palliative Care

(p.283) Chapter 10 Oncology and Palliative Care
Best of Five MCQs for the Acute Medicine SCE
Nigel Lane, Louise Powter, Sam Patel
Oxford University Press

A 56-year-old man was receiving palliative chemotherapy with cisplatin and pemetrexed for right-sided malignant mesothelioma. He presented to the emergency department with worsening right-sided chest pain. The pain was 8/10 in severity and on further questioning there was a sensation of burning associated with it. A chest X-ray showed thickening of the pleura in the right hemithorax consistent with the known diagnosis of mesothelioma. He was taking two tablets of co-codamol 30/500 every six hours to relieve the pain. His eGFR was 90 mL/min.

Keywords:   adjuvant analgesia, caecal adenocarcinoma, demeclocycline, euvolaemic hyponatraemia, fluoropyrimidine-induced vasospasm, germ cell cancer, malignant mesothelioma, neutropenic sepsis, oncology

Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .